Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Omalizumab for the treatment of Bullous Pemphigoid. Spanish multicenter real-world experience.
Aguado Vázquez Á, Estébanez Corrales A, Melgosa-Ramos FJ, Mascaró Galy JM, Fulgencio-Barbarin J, Bosch Amate X, Curto Barredo L, Blanes-Martínez M, Ruiz Villaverde R, Ballester Martínez A, Martín-Torregrosa D, Castaño Fernández JL, Cabeza Martínez R, Pérez-Ferriols A, Ramos Rodríguez D, Boix Vilanova J, Melé-Ninot G, Expósito Serrano V, Alonso AE, Mateu-Puchades A. Aguado Vázquez Á, et al. Among authors: bosch amate x. Clin Exp Dermatol. 2024 Mar 2:llae067. doi: 10.1093/ced/llae067. Online ahead of print. Clin Exp Dermatol. 2024. PMID: 38430106
Esophageal involvement in DPP4 inhibitor-associated bullous pemphigoid.
Brufau-Cochs M, Alamon-Reig F, Luque-Luna M, Bosch-Amate X, Moreta MJ, Bassegoda O, Mascaró JM Jr. Brufau-Cochs M, et al. Among authors: bosch amate x. J Dtsch Dermatol Ges. 2024 Mar;22(3):430-432. doi: 10.1111/ddg.15304. Epub 2024 Jan 29. J Dtsch Dermatol Ges. 2024. PMID: 38286622 No abstract available.
Use of omalizumab is associated with improvement of pruritic skin disorders induced by immune checkpoint inhibitors: A retrospective cohort from the European Task Force of Dermatology for Cancer patients.
Alamon-Reig F, Bosch-Amate X, Giavedoni P, Nikolaou V, Mangas C, Apalla Z, Mayor A, Oikonomou C, Starace M, Sibaud V, Carrera C. Alamon-Reig F, et al. Among authors: bosch amate x. J Am Acad Dermatol. 2024 Feb;90(2):429-432. doi: 10.1016/j.jaad.2023.10.012. Epub 2023 Oct 14. J Am Acad Dermatol. 2024. PMID: 37844688 No abstract available.
[IgA-Anti-p200-Pemphigoid mit areolärem Tropismus].
Buján-Bonino C, Bosch-Amate X, Hashimoto T, Ishii N, Mascaró JM Jr. Buján-Bonino C, et al. Among authors: bosch amate x. J Dtsch Dermatol Ges. 2023 Sep;21(9):1038-1040. doi: 10.1111/ddg.15130_g. J Dtsch Dermatol Ges. 2023. PMID: 37700423 German. No abstract available.
IgA anti-p200 pemphigoid with areolar tropism.
Buján-Bonino C, Bosch-Amate X, Hashimoto T, Ishii N, Mascaró JM Jr. Buján-Bonino C, et al. Among authors: bosch amate x. J Dtsch Dermatol Ges. 2023 Sep;21(9):1038-1040. doi: 10.1111/ddg.15130. Epub 2023 Jun 27. J Dtsch Dermatol Ges. 2023. PMID: 37376797 No abstract available.
Case Report: Localized bullous pemphigoid induced by local triggers: a case series and a proposal for diagnostic criteria based on a literature review.
Corbella-Bagot L, Gil-Lianes J, Fernández-Vela J, Martí-Martí I, Alegre-Fernández M, Fuertes I, Garbayo-Salmons P, Bosch-Amate X, Guilabert A, Mascaró JM Jr. Corbella-Bagot L, et al. Among authors: bosch amate x. Front Immunol. 2023 Jun 2;14:1160779. doi: 10.3389/fimmu.2023.1160779. eCollection 2023. Front Immunol. 2023. PMID: 37334352 Free PMC article. Review.
45 results